New compound shows promise in treating hard-to-treat inflammatory conditions Post author:admin Post published:April 24, 2025 Post category:uncategorized Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. You Might Also Like Study links tanning bed use to rising melanoma rates in New England November 7, 2024 Study links e-cigarette use to increased respiratory symptoms August 2, 2024 FDA Approves Rezdiffra, the First Drug for Advanced Liver Disease March 26, 2024